NewMed Energy (NWMD) Status update summary
Event summary combining transcript, slides, and related documents.
Status update summary
9 Feb, 2026Production and reserves
Leviathan natural gas reservoir holds 19.5 tcf 2P reserves and 43 mmbbl condensate, with 62.9 bcm gas and 5.0 mmbbl condensate produced to date.
Current production capacity is 12 BCM/year, increasing to 14 BCM/year, with plans for 21+ BCM/year after expansion.
Sales distribution includes Israel, Jordan, and Egypt, with annual sales rising from 7.3 BCM in 2020 to 11.4 BCM in 2024.
Financial performance and dividends
EBITDA increased from $587M in 2020 to $1,144M in 2023, with $758.3M reported for Q1-Q3 2025.
Dividends grew from $65M in 2020 to $250M in 2024, with $180M distributed in Q1-Q3 2025.
Expansion and development
Final investment decision signed for Leviathan expansion, targeting capacity increase to 21+ BCM/year.
Export infrastructure upgrades include new gathering lines and debottlenecking, raising total export capacity to 25.5 BCM/year, with Leviathan's share at 16.25 BCM/year.
Aphrodite field, with 3.6 tcf 2C resources, is expected to produce 800 mmcf/d, targeting Egypt and regional export markets.
Latest events from NewMed Energy
- Net profit fell on lower prices and impairment, but capacity and dividends remain strong.NWMD
Q4 202516 Mar 2026 - Net profit rose to $525M on record production, with major expansion and export plans advancing.NWMD
Q4 202417 Feb 2026 - Q3 2025 saw 3.1 BCM gas sales, $128.5M net profit, and $60M dividend distribution.NWMD
Q3 202517 Feb 2026 - Q1 2025 net profit was $116.4M, with strong revenues, project progress, and active capital management.NWMD
Q1 20253 Feb 2026 - Q2 net profit hit $137M as gas output, prices, and expansion projects advanced.NWMD
Q2 20242 Feb 2026 - Record profit and production growth, with strong sales despite war-related project delays.NWMD
Q3 202413 Jan 2026 - Q2 2025 profit fell on production halts, but new gas deals and expansion support growth.NWMD
Q2 202523 Nov 2025